Lupus nephritis (LN) is severe renal comorbidity associated with systemic lupus
erythematosus (SLE), a complex autoimmune disorder with high morbidity and mortality …

Metabolomics has been applied to explore altered metabolite profiles in disease and identify
unique metabolic signatures specific to certain pathologies. The aim of the current study is to …

Lupus nephritis (LN) is a major cause of morbidity and mortality in lupus. Renal biopsy is the
gold standard for classification of nephritis, but because of its impracticality, new approaches …

Lupus nephritis (LN) is one of the most severe manifestations of systemic lupus
erythematosus (SLE), which is associated with significant morbidity and mortality of SLE …

Lupus nephritis (LN), a major complication in individuals diagnosed with systemic lupus
erythematosus, substantially increases morbidity and mortality. Despite marked …

Patients with systemic lupus erythematosus frequently develop lupus nephritis (LN), a
condition that can lead to end-stage kidney disease. Multiple serum and urine biomarkers …

Background The development of personalized medicine using high-throughput methods,
such as metabolomics profiling, in discovering and validating biomarkers, may play a key …

Background Lupus nephritis (LN) occurs in 50% of patients with systemic lupus
erythematosus (SLE), causing considerable morbidity and even mortality. Previous studies …

Systemic lupus erythematosus (SLE) is the prototypical systemic autoimmune disorder.
Kidney involvement, termed lupus nephritis (LN), is seen in 40–60% of patients with …

Lupus nephritis (LN) is a severe clinical manifestation of systemic lupus erythematosus
(SLE) associated with significant morbidity and mortality. Assessment of severity and activity …